{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:58:24Z","timestamp":1761541104668},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T00:00:00Z","timestamp":1346025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T00:00:00Z","timestamp":1346025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1038\/leu.2012.243","type":"journal-article","created":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T06:42:57Z","timestamp":1346049777000},"page":"743-746","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells"],"prefix":"10.1038","volume":"27","author":[{"given":"C","family":"Preisinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J P","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O B","family":"Bleijerveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P J","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K I","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Kolch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Scholten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A J R","family":"Heck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,27]]},"reference":[{"key":"BFleu2012243_CR1","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/nrc2900","volume":"10","author":"W Kolch","year":"2010","unstructured":"Kolch W, Pitt A . Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nat Rev Cancer 2010; 10: 618\u2013629.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2012243_CR2","doi-asserted-by":"publisher","first-page":"7414","DOI":"10.1073\/pnas.0900653106","volume":"106","author":"M Brehme","year":"2009","unstructured":"Brehme M, Hantschel O, Colinge J, Kaupe I, Planyavsky M, Kocher T et al. Charting the molecular network of the drug target Bcr-Abl. Proc Natl Acad Sci USA 2009; 106: 7414\u20137419.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2012243_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nm0596-561","volume":"2","author":"BJ Druker","year":"1996","unstructured":"Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 1996; 2: 561\u2013566.","journal-title":"Nat Med"},{"key":"BFleu2012243_CR4","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1182\/blood-2011-01-330621","volume":"118","author":"GV Helgason","year":"2011","unstructured":"Helgason GV, Karvela M, Holyoake TL . Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML. Blood 2011; 118: 2035\u20132043.","journal-title":"Blood"},{"key":"BFleu2012243_CR5","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1074\/mcp.M900285-MCP200","volume":"8","author":"C Pan","year":"2009","unstructured":"Pan C, Olsen JV, Daub H, Mann M . Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics. Mol Cell Proteomics 2009; 8: 2796\u20132808.","journal-title":"Mol Cell Proteomics"},{"key":"BFleu2012243_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1074\/mcp.M900291-MCP200","volume":"9","author":"PJ Boersema","year":"2010","unstructured":"Boersema PJ, Foong LY, Ding VM, Lemeer S, van Breukelen B, Philp R et al. In-depth qualitative and quantitative profiling of tyrosine phosphorylation using a combination of phosphopeptide immunoaffinity purification and stable isotope dimethyl labeling. Mol Cell Proteomics 2010; 9: 84\u201399.","journal-title":"Mol Cell Proteomics"},{"key":"BFleu2012243_CR7","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1182\/blood-2005-08-3399","volume":"107","author":"VL Goss","year":"2006","unstructured":"Goss VL, Lee KA, Moritz A, Nardone J, Spek EJ, MacNeill J et al. A common phosphotyrosine signature for the Bcr-Abl kinase. Blood 2006; 107: 4888\u20134897.","journal-title":"Blood"},{"key":"BFleu2012243_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nbt0307-285","volume":"25","author":"R Amanchy","year":"2007","unstructured":"Amanchy R, Periaswamy B, Mathivanan S, Reddy R, Tattikota SG, Pandey A . A curated compendium of phosphorylation motifs. Nat Biotechnol 2007; 25: 285\u2013286.","journal-title":"Nat Biotechnol"},{"key":"BFleu2012243_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nrc1567","volume":"5","author":"R Ren","year":"2005","unstructured":"Ren R . Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 2005; 5: 172\u2013183.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2012243_CR10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0092-8674(03)01077-8","volume":"116","author":"T Pawson","year":"2004","unstructured":"Pawson T . Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell 2004; 116: 191\u2013203.","journal-title":"Cell"},{"key":"BFleu2012243_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0092-8674(05)80094-7","volume":"75","author":"AM Pendergast","year":"1993","unstructured":"Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N et al. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 1993; 75: 175\u2013185.","journal-title":"Cell"},{"key":"BFleu2012243_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1478-811X-7-22","volume":"7","author":"FU Wohrle","year":"2009","unstructured":"Wohrle FU, Daly RJ, Brummer T . Function, regulation and pathological roles of the Gab\/DOS docking proteins. Cell Commun Signal 2009; 7: 22.","journal-title":"Cell Commun Signal"},{"key":"BFleu2012243_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S1535-6108(02)00074-0","volume":"1","author":"M Sattler","year":"2002","unstructured":"Sattler M, Mohi MG, Pride YB, Quinnan LR, Malouf NA, Podar K et al. Critical role for Gab2 in transformation by BCR\/ABL. Cancer cell 2002; 1: 479\u2013492.","journal-title":"Cancer cell"},{"key":"BFleu2012243_CR14","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00018-009-0213-1","volume":"67","author":"N Tikhmyanova","year":"2010","unstructured":"Tikhmyanova N, Little JL, Golemis EA . CAS proteins in normal and pathological cell growth control. Cell Mol Life Sci 2010; 67: 1025\u20131048.","journal-title":"Cell Mol Life Sci"},{"key":"BFleu2012243_CR15","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.cellsig.2009.12.012","volume":"22","author":"C Preisinger","year":"2010","unstructured":"Preisinger C, Kolch W . The Bcr-Abl kinase regulates the actin cytoskeleton via a GADS\/Slp-76\/Nck1 adaptor protein pathway. Cell Signal 2010; 22: 848\u2013856.","journal-title":"Cell Signal"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2012243.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2012243","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2012243.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:46:57Z","timestamp":1648741617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2012243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,27]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["BFleu2012243"],"URL":"https:\/\/doi.org\/10.1038\/leu.2012.243","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,27]]},"assertion":[{"value":"27 August 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}